Editorial - Volume 33, Issue

Medical writing transcends borders, uniting professionals across geographies, demographics, languages, and cultures. This inherent global perspective has inspired the theme for this issue. While previous editions have explored medical writing in…

Medical Communications and Writing for Patients - Volume 32, Issue

Introducing a new EMWA Special Interest Group: Communicating with the Public Contributors: Sampoorna Rappaz (author), Lisa Chamberlain James (section editor) The Communicating with the Public Special Interest Group (CwP SIG) held its first Meet…

Veterinary Medical Writing - Volume 33, Issue

Section Editor: Louisa Marcombes Spotlight on www.LAS-interactive.de: Information for animal experimentation and a useful resource for veterinary medical writers Authors: Cemile Jakupoglu, Jennifer Freymann According to the EU Animal Protection…

Getting Your Foot in the Door - Volume 31, Issue

Contributors: Bruna Landeira (author), Ivana Turek (section editor) What piece of advice do aspiring medical writers tend to ignore? - Bruna Landeira Medical Writing. 2022;31(4)86-87. https://doi.org/10.56012/quyl2082

Regulatory writing for rare disease: An interview with Kelley Hill - Volume 34, Issue

Over her 40-year career, Kelley Hill has become regarded as an industry expert in strategic, high-quality, and impactful regulatory writing, especially in the rare disease space. Now enjoying a slower pace of life having retired in 2023, she has led…

Implantable medical devices: Preclinical testing in new product development – on the road to clinical reality - Volume 31, Issue

Implantable medical devices (IMDs) have restored viable and meaningful lives to millions of people who would have otherwise continued to be severely restricted or suffered early death due to their pathologies. Research and development of IMDs are…

Five questions for Ruggero Galici on nonclinical medical writing - Volume 32, Issue

Ruggero Galici is Senior Director of Nonclinical and Clinical Pharmacology Medical Writing at Alexion Pharmaceuticals Inc, AstraZeneca Rare Disease Unit and heads up global early phase regulatory medical writing activities. In this role, he…

Medical Communications and Writing for Patients - Volume 33, Issue

Section Editor: Lisa Chamberlain James Encouraging vaccination through clever and abstruse incentives Author: Yannick Borkens The COVID-19 pandemic kept the world on tenterhooks for several years beginning in 2019. Well over 7 million people had…

Writing for patients: When and how? - Volume 29, Issue

The move towards patient engagement and patient involvement in healthcare decisions (“shared care”) has triggered a raft of new guidances from regulatory authorities, accompanied by new regulations mandating that pharmaceutical companies engage with…

Medical Communications and Writing for Patients - Volume 33, Issue

Section Editor: Lisa Chamberlain James

Involving patients in company-sponsored medical publications: Learning from collaboration with a patient advocacy group to engage patient authors

Authors: Aki Yoshikawa, Atsuko Iwata, Miho Hatano, Yuko Koji…